GB Sciences (STU:18C) EBIT per Share : €-0.00 (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GB Sciences EBIT per Share?

GB Sciences's EBIT per Share for the three months ended in Sep. 2024 was €0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 17.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 42.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 37.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for GB Sciences's EBIT per Share or its related term are showing as below:

STU:18C' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -97.6 Med: 25.9 Max: 76.6
Current: 17

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of GB Sciences was 76.60% per year. The lowest was -97.60% per year. And the median was 25.90% per year.

STU:18C's 3-Year EBIT Growth Rate is ranked better than
61.02% of 1234 companies
in the Biotechnology industry
Industry Median: 7.95 vs STU:18C: 17.00

GB Sciences's EBIT for the three months ended in Sep. 2024 was €-0.14 Mil.

GB Sciences EBIT per Share Historical Data

The historical data trend for GB Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GB Sciences EBIT per Share Chart

GB Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

-0.04

-0.01

GB Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-	-

GB Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

GB Sciences's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.052	/	396.729
=	-0.00

GB Sciences's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.142	/	407.071
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00

GB Sciences (STU:18C) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

GB Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of GB Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

GB Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (STU:18C) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

GBLX:USA

Address

9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148

Website

https://www.gbsciences.com

GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments. The company's intellectual property covers various medical conditions, from which five drug development programs are in the preclinical stage of drug development including its formulations for Parkinson's disease (PD), chronic pain, cytokine release syndrome, depression, and cardiovascular therapeutic programs.

GB Sciences Headlines

No Headlines